gland pharma glp-1 capacity expansion capex Forbes India | Indian pharma's US exposure has shifted sharply since FY20, with most majors trimming reliance on America even as Washington weighs tariffs India's pharma sector is back
Pay in 4 interest-free payments of $5.99 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5



























